RESUMEN
Common pharmacological treatments of mood disorders aim to modulate serotonergic neurotransmission and enhance serotonin levels in the brain. Brain serotonin levels are dependent on the availability of its food-derived precursor essential amino acid tryptophan (Trp). We tested the hypothesis that delivery of Trp via food may serve as an alternative treatment, and examined the effects of a Trp-rich, bioavailable dietary supplement from egg protein hydrolysate on cognitive and emotional functions, mood state, and sleep quality. In a randomised, placebo-controlled, parallel trial, fifty-nine mentally and physically healthy women aged 45-65 years received placebo (n 30) or the supplement (n 29) (both as 0.5 g twice per d) for 19 d. Emotional processing was significantly changed by supplementation, exhibiting a shift in bias away from negative stimuli. The results for the Affective Go/No-Go Task exhibited a slowing of responses to negative words, suggesting reduced attention to negative emotional stimuli. The results for the Facial Emotional Expression Rating Task also supported a shift away from attention to negative emotions and a bias towards happiness. An increase in arousal-like symptoms, labelled 'high energy', shorter reaction times and a slight benefit to sustained attention were observed in the treated subjects. Finally, when the supplement was taken 60-90 min before bedtime, a feeling of happiness before going to bed was consistently reported. In summary, daily consumption of a low-dose supplement containing bioavailable Trp may have beneficial effects on emotional and cognitive functions.
Asunto(s)
Disfunción Cognitiva/prevención & control , Suplementos Dietéticos , Proteínas Dietéticas del Huevo/uso terapéutico , Fatiga Mental/prevención & control , Hidrolisados de Proteína/uso terapéutico , Estrés Psicológico/prevención & control , Triptófano/uso terapéutico , Anciano , Antidepresivos/efectos adversos , Antidepresivos/sangre , Antidepresivos/metabolismo , Antidepresivos/uso terapéutico , Bebidas , Disfunción Cognitiva/sangre , Disfunción Cognitiva/metabolismo , Estudios de Cohortes , Depresión/sangre , Depresión/metabolismo , Depresión/prevención & control , Suplementos Dietéticos/efectos adversos , Método Doble Ciego , Proteínas Dietéticas del Huevo/efectos adversos , Proteínas Dietéticas del Huevo/metabolismo , Metabolismo Energético , Femenino , Humanos , Fatiga Mental/sangre , Fatiga Mental/metabolismo , Persona de Mediana Edad , Nootrópicos/efectos adversos , Nootrópicos/sangre , Nootrópicos/metabolismo , Nootrópicos/uso terapéutico , Hidrolisados de Proteína/efectos adversos , Hidrolisados de Proteína/metabolismo , Escalas de Valoración Psiquiátrica , Tiempo de Reacción , Serotoninérgicos/efectos adversos , Serotoninérgicos/sangre , Serotoninérgicos/metabolismo , Serotoninérgicos/uso terapéutico , Trastornos del Sueño-Vigilia/sangre , Trastornos del Sueño-Vigilia/metabolismo , Trastornos del Sueño-Vigilia/prevención & control , Estrés Psicológico/sangre , Estrés Psicológico/metabolismo , Triptófano/efectos adversos , Triptófano/sangre , Triptófano/metabolismoRESUMEN
RATIONALE: Effective functioning of the neurotransmitter serotonin is important for optimal cognitive and emotional function. Dietary supplements able to increase availability to the brain of the precursor amino acid, tryptophan (TRP), and thereby enhance serotonin synthesis, can have measurable impact on these psychological processes. OBJECTIVES: This study involves a randomised controlled trial of a TRP-rich egg-white protein hydrolysate (DSM Nutritional Products Ltd., Switzerland) on plasma amino acids, cognition, mood and emotional processing in older women. METHODS: Following a baseline test day without treatment, 60 healthy women aged 45-65 years received drinks containing either 2 or 4 g of TRP-rich protein hydrolysate product or 3.11 g casein hydrolysate as a control. One hour later, they undertook a 2-h battery of cognitive and emotional tests. RESULTS: The TRP-rich protein hydrolysate produced the expected dose-dependent increase in the ratio of plasma TRP to competing large neutral amino acids. TRP-rich protein hydrolysate (2 g only) prevented both the decline in wellbeing and increase in fatigue seen over the test session in the control group. This treatment dose resulted in a significant shift in emotional processing towards positive words and reduced negative bias in assessing negative facial expressions. Effects on cognition were small and not statistically reliable and are not reported here. However, there was no evidence for any adverse effects. CONCLUSIONS: Consumption of a low dose of TRP-rich protein hydrolysate may have beneficial effects on emotional function that could promote feelings of wellbeing, possibly conferring resistance to deterioration in mood in healthy subjects or depressive episodes.
Asunto(s)
Afecto/efectos de los fármacos , Aminoácidos/sangre , Suplementos Dietéticos , Emociones/efectos de los fármacos , Hidrolisados de Proteína/farmacología , Anciano , Caseínas , Cognición/efectos de los fármacos , Método Doble Ciego , Femenino , Humanos , Persona de Mediana Edad , Pruebas Neuropsicológicas , Serotonina/metabolismo , Triptófano/sangreRESUMEN
PURPOSE: To establish the threshold level of canthaxanthin crystals in the retina of cynomolgus monkeys. To correlate the spatial distribution of all-trans canthaxanthin and its metabolites with the grade of crystals. METHODS: Monkeys were orally administered 0, 0.2, 0.6, 1.8, 5.4, 16.2, and 48.6 mg/kg body wt canthaxanthin daily for 2.5 to 3 years. A second group of monkeys were administered 200 and 500 mg/kg body wt/d for 5 years. Ophthalmoscopy, electroretinography (ERG), retina and carotenoid analysis were performed as previously reported. RESULTS: Crystals in the retina periphery were observed by ophthalmoscopy preterminally only in the extreme high doses of 200 to 500 mg/kg body wt/d. There were no adverse effects on visual functions as measured by ERG. Crystals in the peripheral retina, and/or in the macula, were detected microscopically in all canthaxanthin treated groups except at the lowest dose of 0.2 mg/kg body wt/d. The grade of crystals increased up to a dose of 16.2 mg/kg body wt/d. Dose-dependent increases in canthaxanthin content also were noted in the retina, the liver, and in plasma. All-trans canthaxanthin was the major compound in the peripheral and paracentral retina of very highly dosed animals, where its concentration correlated largely with the grade of inclusions. In the macula, 4'-OH-echinenone was the dominant canthaxanthin metabolite. CONCLUSIONS: The grade of crystals in monkey retinas was dose dependent with a threshold level at 0.6 mg canthaxanthin/kg body wt/d. It correlated in the retinal periphery with the concentrations of all-trans-canthaxanthin and in the macula with its metabolites.
Asunto(s)
Cantaxantina/administración & dosificación , Cantaxantina/farmacocinética , Retina/efectos de los fármacos , Enfermedades de la Retina/inducido químicamente , Administración Oral , Animales , Cantaxantina/toxicidad , Cristalización , Relación Dosis-Respuesta a Droga , Electrorretinografía , Femenino , Hígado/efectos de los fármacos , Hígado/metabolismo , Hígado/patología , Macaca fascicularis , Masculino , Oftalmoscopía , Retina/metabolismo , Retina/patología , Enfermedades de la Retina/metabolismo , Enfermedades de la Retina/patologíaRESUMEN
Cell lines were established by a two-step method from osteomas which had been induced by infection of mice with RFB MuLV, a bone-pathogenic, replication-competent murine retrovirus. The benign tumors, consisting of mature lamellar bone and surrounded by a thin periosteum, were cultured on sponges of denatured collagen type I fibres for up to 4 weeks. At this time osteoma cells had grown into the collagenous matrix. After release and further cultivation in monolayers, the cell lines established from these cultures varied in morphology; they expressed T1, collagen type I and type III, alkaline phosphatase, osteonectin and osteopontin mRNAs at variable levels, but not osteocalcin/BGP. They also showed alkaline phosphatase activity, but lacked responsiveness to parathyroid hormone. All cell lines established from infected mice expressed retroviral and c-myc mRNA and viral protein. In contrast to cells from control mice they showed an extended life span in culture. After growth in a three-dimensional (3-D) collagen sponge culture the cells formed an extracellular matrix containing collagen type I, alkaline phosphatase and osteocalcin/BGP. These data indicate that the two-step method facilitates the establishment of osteoblast-like cell lines from osteomas and calvaria of old mice, and provides means for further analyses of retrovirus-induced skeletal pathogenesis and bone induction.
Asunto(s)
Neoplasias Óseas/virología , Virus de la Leucemia Murina/fisiología , Osteoblastos/citología , Osteoma/virología , Infecciones por Retroviridae/virología , Fosfatasa Alcalina/metabolismo , Animales , Neoplasias Óseas/patología , Diferenciación Celular/fisiología , División Celular/fisiología , Ratones , Ratones Endogámicos CBA , Ratones Endogámicos , Osteoma/patología , Hormona Paratiroidea/metabolismo , Proteínas Proto-Oncogénicas c-myc/biosíntesis , Células Tumorales Cultivadas , Replicación ViralRESUMEN
PURPOSE: To reproduce and investigate in a primate animal model the phenomenon of the red carotenoid canthaxanthin (beta, beta-carotene-4'4'-dione) to induce crystal-like retinal deposits as they have been observed in the ocular fundus of humans after high canthaxanthin intake (i.e., more than 30 mg/day). METHODS: Groups of four cynomolgus monkeys (Macaca fascicularis) per gender and dose were administered 5.4, 16.2, or 48.6 mg canthaxanthin/kg body weight daily by oral gavage for 2.5 years. Eight control animals received placebo. In vivo ophthalmoscopy was performed at intervals of 3 months along with electroretinography after 12 and 24 months and retinal biomicroscopy just before the monkeys were killed. Retinal wholemounts or frozen sections were investigated postmortem by polarization, bright field, and differential interference contrast microscopy. Retinal and preterminal plasma canthaxanthin concentrations were determined by high-performance liquid chromatography (HPLC). RESULTS: By ophthalmoscopy and retinal biomicroscopy in vivo, no crystals or other light-reflecting particles were observed in the central paramacular retina. However, postmortem polarization microscopy of all 24 canthaxanthin-treated animals showed a circular zone in the peripheral retina containing birefringent, polymorphous red, orange, or white inclusions. The density of these inclusions was diminished within 1 to 8 mm posterior to the ora serrata. These inclusions were located mainly in the inner retinal layers, that is the nerve fiber layer and ganglion cell layer, inner plexiform layer, and inner nuclear layer. Twelve of the 24 canthaxanthin-treated animals showed yellow, golden birefringent inclusions in the macula. Retinas of placebo-treated monkeys were free of birefringent, crystal-like inclusions. The HPLC confirmed the presence of all-trans canthaxanthin, and 4-OH-echinenone and isozeaxanthin as well, in the retinas of all canthaxanthin-treated animals. Neither electroretinography nor histopathology indicated any adverse effects of the canthaxanthin-induced retinal inclusions seen in this study. CONCLUSIONS: A high intake of canthaxanthin for 2.5 years led to the deposition of crystal-like birefringent inclusions in the inner layers of the peripheral retina and, to some extent, the central retina of cynomolgus monkeys. The presence of these deposits did not interfere with morphology nor with retinal function.
Asunto(s)
Cantaxantina/toxicidad , Colorantes de Alimentos/toxicidad , Retina/efectos de los fármacos , Enfermedades de la Retina/inducido químicamente , Animales , Cantaxantina/administración & dosificación , Cromatografía Líquida de Alta Presión , Cristalización , Modelos Animales de Enfermedad , Electrorretinografía , Femenino , Colorantes de Alimentos/administración & dosificación , Macaca fascicularis , Masculino , Oftalmoscopía , Retina/patología , Retina/fisiología , Enfermedades de la Retina/patología , Enfermedades de la Retina/fisiopatologíaRESUMEN
hMt-c-fos-LTR transgenic mice (U. Rüther, D. Komitowski, F. R. Schubert, and E. F. Wagner. Oncogene 4, 861-865, 1989) developed bone sarcomas in 20% (3/15) of females at 448 +/- 25 days and in 8% (1/12) of males at 523 days. After infection of newborns with Akv, an infectious retrovirus derived from the ecotropic provirus of the AKR mouse, 69% (20/28) of female animals and 83% (24/29) of males developed malignant fibrous-osseous tumors. The tumors in infected transgenics developed with higher frequency and a 200-days shorter mean tumor latency period. The hMt-c-fos-LTR transgene was expressed in all the fibrous-osseous tumors. They also showed newly integrated Akv proviruses, but in most tumors Akv was detected and expressed in only a small number of the tumor cells. Wild-type C3H mice infected with Akv developed benign osteomas with an incidence of 33% and a latency period of 474 days. The data indicate that Akv exerts distinct pathogenic effects on the skeleton. In hMt-c-fos-LTR transgenic mice, predisposed to bone sarcomagenesis, Akv acts synergistically with the fos transgene, resulting in the development of fibrous-osseous tumors.
Asunto(s)
Virus de la Leucemia Murina AKR/patogenicidad , Neoplasias Óseas/virología , Genes fos , Sarcoma Experimental/virología , Infecciones Tumorales por Virus/virología , Animales , Secuencia de Bases , Neoplasias Óseas/genética , Cartilla de ADN , Femenino , Masculino , Ratones , Ratones Endogámicos C3H , Ratones Transgénicos , Datos de Secuencia Molecular , Secuencias Repetitivas de Ácidos Nucleicos , Sarcoma Experimental/genética , Infecciones Tumorales por Virus/genéticaAsunto(s)
Corteza Suprarrenal/metabolismo , Ácido Ascórbico/farmacología , Hidrocortisona/metabolismo , Osteoblastos/metabolismo , Osteocalcina/metabolismo , Corteza Suprarrenal/efectos de los fármacos , Hormona Adrenocorticotrópica/farmacología , Animales , Calcitriol/farmacología , Células Cultivadas , Osteoblastos/efectos de los fármacos , Ratas , PorcinosRESUMEN
A tumour cell line was established from a non-metastatic osteosarcoma which had developed in the right femur after infection of a newborn mouse with FBR osteosarcoma virus (FBR MSV). After 20 cell culture passages and injection of the cells into newborn syngeneic mice, the animals developed fibrosarcomas on the site of injection. Metastatic lung tumours were detected in 50% of the mice. Metastatic tumour growth was preferentially observed in the walls of large blood vessels and in subpleural zones. Large areas of the metastatic tumours resembled mature connective tissue. This model of in vitro progression from a primary non-metastasizing osteosarcoma to a neoplasm with particular metastatic potency, though with a growth pattern similar to fibromatosis may serve as a useful system to study the different steps of metastatic progression, distinct tropism of invasive cells and fibrous maturation of metastatic tumours.
Asunto(s)
Fibrosarcoma/patología , Genes fos , Neoplasias Pulmonares/secundario , Osteosarcoma/patología , Animales , Animales Recién Nacidos , Femenino , Neoplasias Femorales/patología , Fibrosarcoma/secundario , Neoplasias Pulmonares/patología , Ratones , Ratones Endogámicos C3H , Trasplante de Neoplasias , Proteínas Oncogénicas v-fos/genética , Osteosarcoma/secundario , Retroviridae/fisiología , Neoplasias Cutáneas/patología , Células Tumorales CultivadasRESUMEN
Osteogenic tumours from c-fos (MT-c-fos-LTR)-transgenic mice and from mice infected with the v-fos-bearing FBR murine osteosarcoma virus (FBR MSV) showed close morphological and neoplastic similarities. Fos mRNA expression was elevated in both types of tumours, and expression of several genes characteristic of differentiated bone cells was either lower, enhanced, or not detectable in comparison to that in normal bone. Tumour-derived cell lines showed variable levels of exogenous fos expression; bone-cell-specific genes were similarly expressed in both primary tumours and tumour-derived cell lines. Upon transplantation the tumour cells formed fibrosarcomas, some of which contained areas of focal osseochondrous differentiation. Non-tumorigenic cell lines established from bone tissue of normal and MT-c-fos-LTR transgenic mice showed osteoblastic characteristics, whereas no parathyroid hormone (PTH) response was observed in transgenic tumour cell lines in spite of high alkaline phosphatase activity. These data indicate that deregulated fos expression interferes with terminal osteogenic differentiation in v-fos- and c-fos-induced bone tumours.